Particularly, in breast cancer cell lines FXR agonists inhibit aromatase expression reducing local estrogens production and induce apoptosis24, whereas other authors have reported that FXR activation stimulates breast cancer cell proliferation27. The gene discussed is CYP19A1; the disease is breast carcinoma.